IVDT_In Vitro Diagnostics Technology

IVD Technology, Spring 2013

Issue link: http://dc.cn.ubm-us.com/i/125322

Contents of this Issue

Navigation

Page 9 of 43

trends & perspectives really favored by what I've worked on in the past six months, year, two to three years. I don't think I go in with any kind of preconception in terms of what I'm looking for. [Te projects that] I've worked on recently are what tend to infuence me, regardless. Tell us a bit about the Chemical Angel Network, of which you are a part. I started the Chemical Angel Network with another cofounder. We invest in early-stage, seed-stage companies. Te cofounder and I saw a need for a technical angel group— a lot of angel groups aren't highly technical. We have had some good traction; we have 20-some members, and Xerox is sponsoring us now. ––Maureen Kingsley the edGe platform by HtG Molecular diagnostics inc. Interface Standard Has IVD Analyzers and IT Systems Talking The IVD Industry Connectivity Consortium (IICC; www.ivdconnectivity.org), working in collaboration with Integrated Healthcare Enterprise (IHE; www.IHE.org) and other standards organizations, has developed a Laboratory Analyzer Workfow (LAW) interface based on a common set of clinical laboratory communication scenarios. Having achieved vali- dation of the LAW at the European IHE 2012 Connectathon in Bern, Switzerland, in May 2012, the organization will exhibit at the AACC Annual Meeting (www.aacc.org) in Houston, TX, from July 28 to August 1 to present the LAW interface to attendees. Interfaces between IVD analyzers and IT systems have been a frus- start your laptops: the european iHe 2012 connectathon. 10 ivd tec HnOLO G Y | sp rin G 2013 magenta cyan yellow black trating and expensive challenge for the clinical laboratory community, according to the IICC. Current standards, last written in the 1980s, provide little guidance and allow for considerable variability and interpretation. Tis has resulted in an ineffcient and cumbersome system of custom interfaces for IVD analyzers, IT systems and clinical laboratories, which has increased costs and errors while reducing quality. Te LAW represents a better way. At the Connectathon, four IVD analyzers and three IT systems using 10 scenarios participated in 129 LAW tests, and each IT system was able to communicate with all four analyzers through the same LAW interface. Te successful demonstration of the standard represented a signifcant step forward for true plug-and-play interoperability between analyzers and IT systems, says the IICC. Companies participating in the Connectathon included Abbott Diagnostics, Orchard Software, Roche Diagnostics, Samsung Electronics, Siemens Healthcare, and Systelab Technologies. Since that event, additional organizations have been working to adopt the standard to i v d t e c hnol ogy. com ES236962_IV1305_010.pgs 04.24.2013 23:37 UBM

Articles in this issue

Links on this page

Archives of this issue

view archives of IVDT_In Vitro Diagnostics Technology - IVD Technology, Spring 2013